跳至主要内容
临床试验/NCT01519739
NCT01519739已完成不适用

Clinical Evaluation of Mediguide System in CRT Implants

Abbott Medical Devices0 个研究点目标入组 15 人开始时间: 2012年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
主要终点
The performance of the MediGuide™ system during CRT implant

研究概览

简要总结

The purpose of this study is to evaluate the safety and performance of the MediGuide™ system during CRT implants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet clinical indication for implantation of an SJM CRT system according to the current European Society of Cardiology (ESC) Guidelines for cardiac and resynchronization therapy
  • Receiving a new implant or undergoing an upgrade from an existing ICD or pacemaker implant with no prior LV lead placement
  • Ability to provide informed consent for study participation and are willing and able to comply with the prescribed follow-up tests and schedule of evaluations

排除标准

  • Currently participating in any other clinical study
  • Have prosthetic valves
  • Are pregnant or planning pregnancy in the next 1 month
  • Are less than 18 years of age
  • Have ventricular tachyarrhythmias resulting from transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction

研究组 & 干预措施

MediGuide Arm

Experimental

干预措施: MediGuide™ (Device)

结局指标

主要结局

The performance of the MediGuide™ system during CRT implant

时间窗: 1 month post CRT implant

Performance will be assessed in terms occurence of adverse events, easy of use and potential benefits.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验